Embolization in Interventional Oncology Market 2021 Analysis by Global Manufacturers - Braile Biomedica, Boston Scientific, Covidien, Merit Medical Systems, Inc., Cook Medical

A latest published report on Global Embolization in Interventional Oncology Market industry analysis and forecast 2021–2026. An analysis report published by Market Intelligence Data is an in-depth study and detailed information regarding the market size, market performance and market dynamics of the Embolization in Interventional Oncology. This market report provides a holistic scope of the market which includes future supply and demand scenarios, changing market trends, high growth opportunities, and in-depth analysis of the future market prospects. This has brought along several changes in market conditions. This report provides latest insights about the market’s drivers, restraints, opportunities, and trends. It also discusses the growth and trends of various segments and the market in various regions. This is a latest report, covering the current COVID-19 impact on the market.

The global market for embolization in interventional oncology predicted to cross $45.3 billion by 2027, growing at a CAGR of 5.0% over the forecast period.

Get a free sample copy of the Embolization in Interventional Oncology market report

https://marketintelligencedata.com/reports/171001/global-embolization-in-interventional-oncology-market-growth-trends-and-forecasts-2015-2025/inquiry?Mode=namita

The major players covered in the Embolization in Interventional Oncology market – Braile Biomedica, Boston Scientific, Covidien, Merit Medical Systems, Inc., Cook Medical, Stryker, Penumbra, Terumo, TERUMO MEDICAL CORPORATION

Industry News and Updates:

Penumbra Introduces POD Packing Coil for the Embolization of Peripheral Vessels and Aneurysms

ALAMEDA, Calif. – Jan. 6, 2016 – Penumbra, Inc., a global interventional therapies company, today announced the U.S. launch of its new POD Packing Coil, designed to be used as a complementary device with Penumbra’s Ruby and POD (Penumbra Occlusion Device) embolization products. This latest launch adds to the company’s rapidly expanding peripheral vascular product portfolio. Nearly 900,000 Americans each year suffer from peripheral vascular conditions involving acute clots or aneurysms that occur outside the brain or heart, and this represents a large and growing patient population.

Market Overview:

Embolization is a minimally invasive therapy to block a blood vessel. It is commonly used to stop bleeding as well as to stop blood flow to a tumor in order to shrink it or in preparation for removal. Embolization is a procedure that injects substances to try to block or reduce the blood flow to cancer cells. It is an option for some patients with tumors that cannot be removed by surgery, and where tumors are too large to be treated with ablation.

Segment by Type

Embolization Devices

Ablation Devices

Support Devices

Segment by Application

Hospitals

Specialty Clinics

The current market situations and prospects of the sector also have been examined. Additionally, prime strategical activities in the market, which include product developments, mergers, and acquisitions, partnerships, etc., are discussed. Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products, etc.)

Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, and revenue and Industry share for each manufacturer covered in this report. This report focuses on global level, regional level and company level and represents overall Embolization in Interventional Oncology Industry size by analyzing historical data and future prospect.

Regional Analysis:

Government efforts to increased funding, supportive regulations for the development and commercialization of advanced interventional oncology products, rising healthcare expenditure, an increasing number of hospitals and clinics in India and China, expanding research base across India, China, and Japan, and the increasing incidence of surgeries are the major factors driving the growth of the APAC interventional oncology market.

The report provides a comprehensive analysis of:

Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

Click the link below to browse full report

https://marketintelligencedata.com/reports/171001/global-embolization-in-interventional-oncology-market-growth-trends-and-forecasts-2015-2025?Mode=namita                             

Customization of the Report: The report can be further customized according to the client’s specific research requirements. No additional charges will be added for limited additional research.           

Note: All the reports that we list have been tracking the impact of COVID-19 on the market. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check with the sales team. 

Contact Us:
Irfan Tamboli (Head of Sales) – Market Intelligence Data
Phone: + 1704 266 3234
sales@marketintelligencedata.com

About Us:

MarketIntelligenceData provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketIntelligenceData provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.